Editorial Commentary: Stem Cell Treatment in Knee Osteoarthritis: What for? Pain Management or Cartilage Regeneration?

Arthroscopy. 2021 Jan;37(1):359-361. doi: 10.1016/j.arthro.2020.11.017.

Abstract

The efficacy of mesenchymal stem cells regarding clinical outcomes and cartilage regeneration in knee osteoarthritis remains unclear; however, their theoretical role in multilineage cellular differentiation and immunomodulation of the arthritic cascade has been investigated. Several studies have reported that the use of stem cell therapy for knee osteoarthritis helps in pain improvement, but its effect on cartilage regeneration has not yet been explored. Moreover, numerous studies have reported high heterogeneity in the cell sources, as well as methods of culture expansion or cell concentration, and differences in delivery methods, assessment tools, and concomitant surgical procedures, which could affect the clinical outcomes or evaluation of cartilage regeneration potency. Furthermore, future studies are warranted to examine these factors in detail to interpret the results of mesenchymal stem cell treatment for knee osteoarthritis.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cartilage
  • Humans
  • Injections, Intra-Articular
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells*
  • Osteoarthritis, Knee* / therapy
  • Pain Management
  • Randomized Controlled Trials as Topic
  • Regeneration